California State Teachers Retirement System Biotechnology

California State Teachers Retirement System

$84.1 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$124B	$192 Million 0.23% of portfolio	412,477	Q3 2024 Reduced 0.82%
REGN Regeneron Pharmaceuticals, Inc.	$83.9B	$182 Million 0.22% of portfolio	173,145	Q3 2024 Reduced 0.34%
ALNY Alnylam Pharmaceuticals, Inc.	$31.7B	$52.6 Million 0.06% of portfolio	191,325	Q3 2024 Reduced 1.17%
MRNA Moderna, Inc.	$15.6B	$34.6 Million 0.04% of portfolio	516,996	Q3 2024 Reduced 0.68%
UTHR United Therapeutics Corp	$17.6B	$25 Million 0.03% of portfolio	69,840	Q3 2024 Reduced 4.02%
RPRX Royalty Pharma PLC	$11.2B	$21.8 Million 0.03% of portfolio	771,930	Q3 2024 Added 5.54%
TECH Bio Techne Corp	$2.85B	$19.2 Million 0.02% of portfolio	239,725	Q3 2024 Reduced 1.22%
BMRN Biomarin Pharmaceutical Inc	$12.2B	$18.7 Million 0.02% of portfolio	266,667	Q3 2024 Reduced 2.41%
INCY Incyte Corp	$17.3B	$15.8 Million 0.02% of portfolio	239,200	Q3 2024 Added 0.03%
INSM Insmed Inc	$9.65B	$10.7 Million 0.01% of portfolio	146,742	Q3 2024 Added 5.77%
PCVX Vaxcyte, Inc.	$5.5B	$10.2 Million 0.01% of portfolio	89,436	Q3 2024 Reduced 2.02%
SRPT Sarepta Therapeutics, Inc.	$9.55B	$10.1 Million 0.01% of portfolio	80,921	Q3 2024 Reduced 2.44%
HALO Halozyme Therapeutics, Inc.	$7.52B	$6.88 Million 0.01% of portfolio	120,206	Q3 2024 Reduced 3.01%
EXEL Exelixis, Inc.	$11.3B	$6.49 Million 0.01% of portfolio	249,904	Q3 2024 Reduced 4.29%
JAZZ Jazz Pharmaceuticals PLC	$7.79B	$6.37 Million 0.01% of portfolio	57,145	Q3 2024 Reduced 1.92%
VKTX Viking Therapeutics, Inc.	$4.11B	$5.97 Million 0.01% of portfolio	94,364	Q3 2024 Reduced 2.36%
CYTK Cytokinetics Inc	$5.15B	$5.53 Million 0.01% of portfolio	104,644	Q3 2024 Added 6.91%
BPMC Blueprint Medicines Corp	$5.71B	$5.23 Million 0.01% of portfolio	56,517	Q3 2024 Reduced 1.11%
RVMD Revolution Medicines, Inc.	$5.03B	$5.07 Million 0.01% of portfolio	111,932	Q3 2024 Reduced 2.91%
IONS Ionis Pharmaceuticals Inc	$5.28B	$5.05 Million 0.01% of portfolio	126,180	Q3 2024 Reduced 2.35%
RARE Ultragenyx Pharmaceutical Inc.	$3.34B	$4.32 Million 0.01% of portfolio	77,783	Q3 2024 Added 5.91%
ADMA Adma Biologics, Inc.	$3.97B	$4.17 Million 0.0% of portfolio	208,674	Q3 2024 Reduced 3.16%
ROIV Roivant Sciences Ltd.	$8.2B	$4.08 Million 0.0% of portfolio	353,721	Q3 2024 Reduced 0.02%
CORT Corcept Therapeutics Inc	$5.87B	$4.06 Million 0.0% of portfolio	87,698	Q3 2024 Reduced 2.64%
RNA Avidity Biosciences, Inc.	$2.6B	$3.56 Million 0.0% of portfolio	77,404	Q3 2024 Reduced 1.94%
DNLI Denali Therapeutics Inc.	$3.82B	$3.53 Million 0.0% of portfolio	121,112	Q3 2024 Added 4.45%
KRYS Krystal Biotech, Inc.	$4.55B	$3.5 Million 0.0% of portfolio	19,261	Q3 2024 Added 4.54%
CRSP Crispr Therapeutics Ag	$3.65B	$3.31 Million 0.0% of portfolio	70,431	Q3 2024 Reduced 3.39%
CRNX Crinetics Pharmaceuticals, Inc.	$3.21B	$3.28 Million 0.0% of portfolio	64,192	Q3 2024 Reduced 2.05%
TGTX Tg Therapeutics, Inc.	$4.48B	$3.24 Million 0.0% of portfolio	138,351	Q3 2024 Reduced 3.07%
NUVL Nuvalent, Inc.	$3.88B	$2.9 Million 0.0% of portfolio	28,333	Q3 2024 Reduced 1.86%
BBIO Bridge Bio Pharma, Inc.	$3.57B	$2.76 Million 0.0% of portfolio	108,267	Q3 2024 Reduced 1.41%
AXSM Axsome Therapeutics, Inc.	$4.18B	$2.66 Million 0.0% of portfolio	29,608	Q3 2024 Reduced 3.09%
MDGL Madrigal Pharmaceuticals, Inc.	$5.18B	$2.64 Million 0.0% of portfolio	12,441	Q3 2024 Reduced 1.72%
ACLX Arcellx, Inc.	$4.25B	$2.6 Million 0.0% of portfolio	31,167	Q3 2024 Reduced 2.8%
VCYT Veracyte, Inc.	$2.65B	$2.46 Million 0.0% of portfolio	72,344	Q3 2024 Reduced 0.9%
PTCT Ptc Therapeutics, Inc.	$3.03B	$2.44 Million 0.0% of portfolio	65,815	Q3 2024 Reduced 3.02%
RYTM Rhythm Pharmaceuticals, Inc.	$3.35B	$2.3 Million 0.0% of portfolio	43,916	Q3 2024 Reduced 1.88%
FOLD Amicus Therapeutics, Inc.	$2.83B	$2.3 Million 0.0% of portfolio	215,335	Q3 2024 Reduced 3.04%
APLS Apellis Pharmaceuticals, Inc.	$3.08B	$2.21 Million 0.0% of portfolio	76,540	Q3 2024 Reduced 2.75%
XENE Xenon Pharmaceuticals Inc.	$2.6B	$2.2 Million 0.0% of portfolio	56,004	Q3 2024 Reduced 3.67%
AGIO Agios Pharmaceuticals, Inc.	$3.04B	$2.17 Million 0.0% of portfolio	48,729	Q3 2024 Reduced 2.21%
IDYA Ideaya Biosciences, Inc.	$1.42B	$2.08 Million 0.0% of portfolio	65,528	Q3 2024 Added 4.32%
ARWR Arrowhead Pharmaceuticals, Inc.	$2.27B	$2.06 Million 0.0% of portfolio	106,293	Q3 2024 Reduced 11.92%
CPRX Catalyst Pharmaceuticals, Inc.	$2.23B	$2.01 Million 0.0% of portfolio	100,957	Q3 2024 Reduced 3.58%
GERN Geron Corp	$1.4B	$1.96 Million 0.0% of portfolio	432,116	Q3 2024 Added 4.26%
CLDX Celldex Therapeutics, Inc.	$1.2B	$1.92 Million 0.0% of portfolio	56,497	Q3 2024 Reduced 1.15%
PTGX Protagonist Therapeutics, Inc	$2.01B	$1.92 Million 0.0% of portfolio	42,665	Q3 2024 Reduced 2.58%
MRUS Merus N.V.	$2.28B	$1.91 Million 0.0% of portfolio	38,277	Q3 2024 Added 6.47%
DYN Dyne Therapeutics, Inc.	$1.57B	$1.9 Million 0.0% of portfolio	52,882	Q3 2024 Reduced 3.02%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.